NCT06246695View on ClinicalTrials.gov

A Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics of Jaktinib in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 27, 2021

Primary Completion Date

January 12, 2022

Study Completion Date

January 12, 2022

Conditions
Healthy Volunteers
Interventions
DRUG

Jaktinib Hydrochloride Tablets

Oral Jaktinib 100 mg for 1 day

DRUG

Itraconazole capsule

Oral Itraconazole 200 mg for 9 day

DRUG

Rifampicin Capsules

Oral Rifampicin 600 mg for 11 day

Trial Locations (1)

233004

The First Affiliated Hospital of Bengbu Medical College, Bengbu

All Listed Sponsors
lead

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

INDUSTRY

NCT06246695 - A Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics of Jaktinib in Healthy Volunteers | Biotech Hunter | Biotech Hunter